002424 ST百灵
已收盘 09-04 15:00:00
资讯
新帖
简况
股市必读：ST百灵新发布《关于第六届董事会第三十次会议决议的公告》
证券之星 · 09-03 01:47
股市必读：ST百灵新发布《关于第六届董事会第三十次会议决议的公告》
ST百灵（002424）披露召开2026年第五次临时股东会通知，9月2日股价下跌1.5%
证券之星 · 09-02 22:37
ST百灵（002424）披露召开2026年第五次临时股东会通知，9月2日股价下跌1.5%
股市必读：ST百灵新发布《关于全资子公司获得药物临床试验批准通知书的公告》
证券之星 · 09-01
股市必读：ST百灵新发布《关于全资子公司获得药物临床试验批准通知书的公告》
图解ST百灵中报：第二季度单季净利润同比下降93.36%
证券之星 · 08-25
图解ST百灵中报：第二季度单季净利润同比下降93.36%
股市必读：ST百灵（002424）7月23日董秘有最新回复
证券之星 · 07-24
股市必读：ST百灵（002424）7月23日董秘有最新回复
ST百灵：截止2026年7月20日股东总户数为58,908
证券之星 · 07-23
ST百灵：截止2026年7月20日股东总户数为58,908
ST百灵（002424）披露公司产品纳入《国家基本药物目录（2026年版）》的公告，7月10日股价上涨1.58%
证券之星 · 07-10
ST百灵（002424）披露公司产品纳入《国家基本药物目录（2026年版）》的公告，7月10日股价上涨1.58%
ST百灵：12个主要在销产品入选2026版国家基药目录
视频滚动新闻 · 07-10
ST百灵：12个主要在销产品入选2026版国家基药目录
ST百灵(002424)6月30日股东户数5.94万户，较上期减少1.41%
证券之星 · 07-09
ST百灵(002424)6月30日股东户数5.94万户，较上期减少1.41%
ST百灵：截止2026年6月30日，公司股东总户数为59,376
证券之星 · 07-07
ST百灵：截止2026年6月30日，公司股东总户数为59,376
ST百灵（002424）披露2026年第四次临时股东会决议公告，7月2日股价上涨4.14%
证券之星 · 07-02
ST百灵（002424）披露2026年第四次临时股东会决议公告，7月2日股价上涨4.14%
异动快报：ST百灵（002424）6月25日10点9分触及跌停板
证券之星 · 06-25
异动快报：ST百灵（002424）6月25日10点9分触及跌停板
异动快报：ST百灵（002424）6月23日9点40分触及涨停板
证券之星 · 06-23
异动快报：ST百灵（002424）6月23日9点40分触及涨停板
ST百灵最新公告：护肝片等产品中选全国中成药采购联盟集中带量采购
证券之星 · 06-21
ST百灵最新公告：护肝片等产品中选全国中成药采购联盟集中带量采购
每周股票复盘：ST百灵（002424）拟注销1209万股并减资
证券之星 · 06-21
每周股票复盘：ST百灵（002424）拟注销1209万股并减资
ST百灵（002424）披露关于变更回购股份用途并注销的公告，6月16日股价下跌0.9%
证券之星 · 06-16
ST百灵（002424）披露关于变更回购股份用途并注销的公告，6月16日股价下跌0.9%
ST百灵（002424）披露2025年度股东会决议公告，5月19日股价上涨1.23%
证券之星 · 05-19
ST百灵（002424）披露2025年度股东会决议公告，5月19日股价上涨1.23%
ST百灵：截止2026年4月30日，公司股东总户数为62393
证券之星 · 05-08
ST百灵：截止2026年4月30日，公司股东总户数为62393
ST百灵（002424）披露2026年第二次临时股东会决议公告，5月6日股价上涨1.99%
证券之星 · 05-06
ST百灵（002424）披露2026年第二次临时股东会决议公告，5月6日股价上涨1.99%
股市必读：ST百灵年报 - 第四季度单季净利润同比下降195.23%
证券之星 · 04-29
股市必读：ST百灵年报 - 第四季度单季净利润同比下降195.23%
加载更多
公司概况
公司名称：
贵州百灵企业集团制药股份有限公司
所属行业：
医药制造业
上市日期：
2010-06-03
主营业务：
贵州百灵企业集团制药股份有限公司的主营业务是苗药研发、生产、销售。公司的主要产品是银丹心脑通软胶囊、咳速停糖浆/胶囊、复方一枝黄花喷雾剂、维C银翘片、小儿柴桂退热颗粒、强力枇杷露、双羊喉痹通颗粒。公司获得了贵州省医药产业骨干企业、全国最大的苗药研制生产企业、2025中国医药市场药企排行榜（中药）TOP100第28位、2026中药研发实力TOP50榜单、第二届“长高赛”最佳商业化潜力奖。
发行价格：
40.00
{"stockData":{"symbol":"002424","market":"SZ","secType":"STK","nameCN":"ST百灵","latestPrice":4.59,"timestamp":1788505416000,"preClose":4.57,"halted":0,"volume":4432300,"delay":0,"changeRate":0.0044,"floatShares":1152000000,"shares":1398000000,"eps":-0.0903,"marketStatus":"已收盘","change":0.02,"latestTime":"09-04 15:00:00","open":4.57,"high":4.61,"low":4.57,"amount":20333700,"amplitude":0.0088,"askPrice":4.59,"askSize":631,"bidPrice":4.58,"bidSize":2153,"shortable":0,"etf":0,"ttmEps":-0.0903,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"adjPreClose":4.57,"symbolType":"stock","openAndCloseTimeList":[[1788485400000,1788492600000],[1788498000000,1788505200000]],"highLimit":4.8,"lowLimit":4.34,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1397598400,"isCdr":false,"pbRate":2.01,"roa":"--","roe":"0.95%","epsLYR":-0.08,"committee":-0.182459,"marketValue":6415000000,"turnoverRate":0.0038,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-07。","floatMarketCap":5287000000},"requestUrl":"/m/hq/s/002424","defaultTab":"news","newsList":[{"id":"2664845395","title":"股市必读：ST百灵新发布《关于第六届董事会第三十次会议决议的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664845395","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664845395?lang=zh_cn&edition=full","pubTime":"2026-09-03 01:47","pubTimestamp":1788371230,"startTime":"0","endTime":"0","summary":"公司公告汇总关于第六届董事会第三十次会议决议的公告贵州百灵企业集团制药股份有限公司于2026年9月2日召开第六届董事会第三十次会议，审议通过《关于修订〈公司章程〉的议案》《关于修订〈董事会议事规则〉的议案》《关于修订〈董事会秘书工作制度〉的议案》及《关于召开2026年第五次临时股东会的议案》。本次修订涉及董事会成员构成，独立董事由4名调整为3名，增设1名职工代表董事，并完善董事会秘书职责条款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0028","BK0239","002424","BK0077","BK0188","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664008817","title":"ST百灵（002424）披露召开2026年第五次临时股东会通知，9月2日股价下跌1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664008817","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664008817?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:37","pubTimestamp":1788359832,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，ST百灵报收于4.6元，较前一交易日下跌1.5%，最新总市值为64.29亿元。该股当日开盘4.68元，最高4.68元，最低4.6元，成交额达3092.34万元，换手率为0.58%。近日，ST百灵披露《关于召开2026年第五次临时股东会通知的公告》。公告显示，公司将于2026年09月18日召开2026年第五次临时股东会，会议由董事会召集，现场会议时间为当日14:00，网络投票时间为同日上午9:15至下午15:00。股权登记日为2026年09月11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0146","BK0183","BK0188","BK0077","BK0239","002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664888583","title":"股市必读：ST百灵新发布《关于全资子公司获得药物临床试验批准通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664888583","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664888583?lang=zh_cn&edition=full","pubTime":"2026-09-01 03:44","pubTimestamp":1788205454,"startTime":"0","endTime":"0","summary":"公司公告汇总：全资子公司百灵毓秀（珠海）医药有限公司收到国家药监局签发的《药物临床试验批准通知书》，创新药吸入用BD77获批开展慢性阻塞性肺病临床试验。吸入用BD77是来源于单一法定中药材的小分子化学药，纯度超过98%，已开展药理学与药效学研究，显示其在多种病原体引起的肺炎模型中具有治疗作用。目前该药尚处于临床试验获批阶段，后续仍需开展临床试验并经审批方可上市，存在研发风险及不确定性，对公司近期业绩无重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100004155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0239","BK0028","BK0077","BK0183","002424","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662930203","title":"图解ST百灵中报：第二季度单季净利润同比下降93.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662930203","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662930203?lang=zh_cn&edition=full","pubTime":"2026-08-25 02:23","pubTimestamp":1787595836,"startTime":"0","endTime":"0","summary":"证券之星消息，ST百灵2026年中报显示，上半年度公司主营收入9.7亿元，同比下降33.62%；归母净利润3002.79万元，同比下降42.07%；扣非净利润2769.23万元，同比上升100.01%；其中2026年第二季度，公司单季度主营收入3.26亿元，同比下降53.47%；单季度归母净利润183.83万元，同比下降93.36%；单季度扣非净利润-98.76万元，同比下降108.06%；负债率43.95%，投资收益-2795.65万元，财务费用2583.2万元，毛利率41.78%。财报数据概要请见下图:本文数据来源于ST百灵2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653572066","title":"股市必读：ST百灵（002424）7月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653572066","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653572066?lang=zh_cn&edition=full","pubTime":"2026-07-24 02:28","pubTimestamp":1784831293,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘，ST百灵报收于4.46元，上涨1.13%，换手率0.44%，成交量5.09万手，成交额2257.13万元。董秘最新回复投资者： 董秘你好，截至今天为止股东人数是多少？董秘： 感谢您对公司的关注，截止2026年7月20日，公司股东总户数为58,908。当日关注点交易信息汇总：7月23日主力资金净流入84.43万元，占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400001677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","002424","BK0239","BK0077","BK0183","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653728444","title":"ST百灵：截止2026年7月20日股东总户数为58,908","url":"https://stock-news.laohu8.com/highlight/detail?id=2653728444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653728444?lang=zh_cn&edition=full","pubTime":"2026-07-23 20:58","pubTimestamp":1784811490,"startTime":"0","endTime":"0","summary":"证券之星消息，ST百灵(002424)07月23日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，截至今天为止股东人数是多少？ST百灵回复：感谢您对公司的关注，截止2026年7月20日，公司股东总户数为58,908。谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300045796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002424","BK0188","BK0146","BK0183","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650350131","title":"ST百灵（002424）披露公司产品纳入《国家基本药物目录（2026年版）》的公告，7月10日股价上涨1.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650350131","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650350131?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:31","pubTimestamp":1783693870,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，ST百灵报收于4.51元，较前一交易日上涨1.58%，最新总市值为63.03亿元。该股当日开盘4.43元，最高4.55元，最低4.39元，成交额达4169.02万元，换手率为0.81%。近日，ST百灵披露《关于公司产品纳入〈国家基本药物目录〉的公告》。公告显示，国家卫生健康委员会于2026年7月9日发布《国家基本药物目录》，自2026年9月1日起施行。其中银丹心脑通软胶囊为公司核心独家产品，系首家中药二级保护品种和《中国药典》首批收载的苗药品种。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000044662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0239","BK0183","BK0028","BK0146","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650476135","title":"ST百灵：12个主要在销产品入选2026版国家基药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2650476135","media":"视频滚动新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650476135?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:27","pubTimestamp":1783693620,"startTime":"0","endTime":"0","summary":"ST百灵(002424)7月10日公告，公司旗下银丹心脑通软胶囊、小儿柴桂退热颗粒、护肝片、强力枇杷露、一清颗粒、牛黄解毒片等12个主要在销产品入选《国家基本药物目录（2026年版）》。ST百灵表示，公司上述产品入选《国家基本药物目录(2026年版)》，是国家层面对公司产品临床价值、质量标准与惠民属性的高度认可；这有利于其在各级医疗机构的推广使用。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：小浪快报","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/videoroll/2026-07-10/doc-inihiwvv5099654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0146","BK0183","BK0188","BK0077","BK0239","002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650401059","title":"ST百灵(002424)6月30日股东户数5.94万户，较上期减少1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650401059","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650401059?lang=zh_cn&edition=full","pubTime":"2026-07-09 17:22","pubTimestamp":1783588979,"startTime":"0","endTime":"0","summary":"证券之星消息，近日ST百灵披露，截至2026年6月30日公司股东户数为5.94万户，较6月10日减少847.0户，减幅为1.41%。在中药行业个股中，ST百灵股东户数高于行业平均水平，截至6月30日，中药行业平均股东户数为5.35万户。从股价来看，2026年6月10日至2026年6月30日，ST百灵区间跌幅为3.98%，在此期间股东户数减少847.0户，减幅为1.41%。根据统计，ST百灵2026年6月10日至2026年6月30日，主力资金净流出4050.25万元，游资资金净流入1655.21万元，散户资金净流入2395.04万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900030642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0183","BK0188","BK0239","002424","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649098062","title":"ST百灵：截止2026年6月30日，公司股东总户数为59,376","url":"https://stock-news.laohu8.com/highlight/detail?id=2649098062","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649098062?lang=zh_cn&edition=full","pubTime":"2026-07-07 20:48","pubTimestamp":1783428495,"startTime":"0","endTime":"0","summary":"证券之星消息，ST百灵(002424)07月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，截止6.30日的股东人数，谢谢！ST百灵回复：感谢您对公司的关注。截止2026年6月30日，公司股东总户数为59,376。谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700039231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0028","002424","BK0077","BK0188","BK0146","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648568648","title":"ST百灵（002424）披露2026年第四次临时股东会决议公告，7月2日股价上涨4.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648568648","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648568648?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:54","pubTimestamp":1783004052,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，ST百灵报收于4.53元，较前一交易日上涨4.14%，最新总市值为63.31亿元。该股当日开盘4.34元，最高4.57元，最低4.31元，成交额达7256.81万元，换手率为1.41%。近日，贵州百灵企业集团制药股份有限公司发布《关于2026年第四次临时股东会决议的公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0146","BK0028","BK0183","BK0239","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646828742","title":"异动快报：ST百灵（002424）6月25日10点9分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2646828742","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646828742?lang=zh_cn&edition=full","pubTime":"2026-06-25 10:11","pubTimestamp":1782353464,"startTime":"0","endTime":"0","summary":"证券之星6月25日盘中消息，10点9分ST百灵（002424）触及跌停板。其所属行业中药目前下跌。领涨股为*ST香雪。该股为腾讯概念股，互联网医疗，流感概念热股。6月24日的资金流向数据方面，主力资金净流出436.71万元，占总成交额5.08%，游资资金净流入277.66万元，占总成交额3.23%，散户资金净流入159.05万元，占总成交额1.85%。近5日资金流向一览见下表：ST百灵主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500012907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0146","BK0183","BK0239","BK0188","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645001576","title":"异动快报：ST百灵（002424）6月23日9点40分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2645001576","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645001576?lang=zh_cn&edition=full","pubTime":"2026-06-23 09:46","pubTimestamp":1782179176,"startTime":"0","endTime":"0","summary":"证券之星6月23日盘中消息，9点40分ST百灵（002424）触及涨停板。其所属行业中药目前上涨。领涨股为粤万年青。该股为医药，中药，创新药概念热股，当日医药概念上涨2.96%，中药概念上涨2.93%，创新药概念上涨2.91%。6月22日的资金流向数据方面，主力资金净流入755.87万元，占总成交额10.89%，游资资金净流出471.7万元，占总成交额6.8%，散户资金净流出284.17万元，占总成交额4.09%。近5日资金流向一览见下表：ST百灵主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300009859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0146","BK0183","BK0239","BK0188","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645092700","title":"ST百灵最新公告：护肝片等产品中选全国中成药采购联盟集中带量采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2645092700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645092700?lang=zh_cn&edition=full","pubTime":"2026-06-21 16:49","pubTimestamp":1782031788,"startTime":"0","endTime":"0","summary":"ST百灵(002424.SZ)公告称，根据湖北医保服务平台17日发布的《关于公布全国中成药采购联盟集中采购中选结果的通知》，公司产品银丹心脑通软胶囊、护肝片、强力枇杷露中选此次中成药采购联盟集中带量采购。此次中选产品银丹心脑通软胶囊为公司核心独家产品，已获批为首家中药二级保护品种。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100002783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0028","002424","BK0146","BK0188","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645538096","title":"每周股票复盘：ST百灵（002424）拟注销1209万股并减资","url":"https://stock-news.laohu8.com/highlight/detail?id=2645538096","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645538096?lang=zh_cn&edition=full","pubTime":"2026-06-21 02:51","pubTimestamp":1781981470,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，ST百灵报收于4.26元，较上周的4.46元下跌4.48%。本周，ST百灵6月15日盘中最高价报4.54元。公司公告汇总贵州百灵企业集团制药股份有限公司于2026年6月16日召开第六届董事会第二十八次会议，审议通过《关于变更回购股份用途并注销的议案》，拟将已回购的12,096,900股股份由用于员工持股计划或股权激励变更为注销并减少注册资本。本次担保后，公司及控股子公司对外担保总余额为24,340万元，占最近一期经审计净资产的7.71%，无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0146","BK0183","002424","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643763790","title":"ST百灵（002424）披露关于变更回购股份用途并注销的公告，6月16日股价下跌0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643763790","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643763790?lang=zh_cn&edition=full","pubTime":"2026-06-16 22:35","pubTimestamp":1781620538,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，ST百灵报收于4.4元，较前一交易日下跌0.9%，最新总市值为61.49亿元。近日，贵州百灵企业集团制药股份有限公司披露《关于变更回购股份用途并注销的公告》。公告显示，公司于2026年6月16日召开第六届董事会第二十八次会议，审议通过《关于变更回购股份用途并注销的议案》。本次注销后，公司总股本将由1,397,598,400股变更为1,385,501,500股，注册资本相应减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600044337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0183","BK0077","002424","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636183056","title":"ST百灵（002424）披露2025年度股东会决议公告，5月19日股价上涨1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636183056","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636183056?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:27","pubTimestamp":1779186435,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，ST百灵报收于4.92元，较前一交易日上涨1.23%，最新总市值为68.76亿元。公司于2026年5月19日发布《关于2025年度股东会决议的公告》。公告显示，贵州百灵企业集团制药股份有限公司于2026年5月18日召开2025年度股东会，会议由董事会召集，代理董事长牛民主持，采用现场与网络投票结合方式召开。出席会议股东共530人，代表股份454,556,829股，占公司有表决权股份总数的32.5241%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900035435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","002424","BK0028","BK0146","BK0183","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633459201","title":"ST百灵：截止2026年4月30日，公司股东总户数为62393","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459201","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633459201?lang=zh_cn&edition=full","pubTime":"2026-05-08 20:51","pubTimestamp":1778244683,"startTime":"0","endTime":"0","summary":"证券之星消息，ST百灵(002424)05月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截止到四月三十日股东人数是多少？谢谢ST百灵回复：感谢您对公司的关注。截止2026年4月30日，公司股东总户数为62393。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800041165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0146","BK0239","BK0188","BK0077","002424","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633132572","title":"ST百灵（002424）披露2026年第二次临时股东会决议公告，5月6日股价上涨1.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633132572","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633132572?lang=zh_cn&edition=full","pubTime":"2026-05-06 22:59","pubTimestamp":1778079552,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，ST百灵报收于5.13元，较前一交易日上涨1.99%，最新总市值为71.7亿元。该股当日开盘5.05元，最高5.13元，最低5.04元，成交额达6276.98万元，换手率为1.02%。近日，贵州百灵企业集团制药股份有限公司发布《关于2026年第二次临时股东会决议的公告》。公告显示，公司于2026年5月6日召开2026年第二次临时股东会，会议采用现场与网络投票相结合方式。出席会议的股东及授权代表共1,047人，代表股份553,277,821股，占公司有表决权股份总数的39.5878%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600040308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0146","BK0188","BK0183","BK0028","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631234537","title":"股市必读：ST百灵年报 - 第四季度单季净利润同比下降195.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631234537","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631234537?lang=zh_cn&edition=full","pubTime":"2026-04-29 07:11","pubTimestamp":1777417889,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，ST百灵报收于5.02元，上涨1.01%，换手率0.82%，成交量9.95万手，成交额5015.22万元。来自股本股东变化：截至4月20日股东户数环比减少0.46%，户均持股上升至2.21万股，筹码集中度有所提升。来自业绩披露要点：2025年归母净利润亏损1.04亿元，同比下滑410.41%，盈利能力显著承压。股本股东变化股东户数变动近日ST百灵披露，截至2026年4月20日公司股东户数为6.32万户，较4月10日减少289.0户，减幅为0.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900018982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788553394374,"stockEarnings":[{"period":"1week","weight":-0.0065},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0},{"period":"6month","weight":-0.1105},{"period":"1year","weight":-0.2059},{"period":"ytd","weight":0.0552}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0133},{"period":"3month","weight":-0.0242},{"period":"6month","weight":-0.0471},{"period":"1year","weight":0.0436},{"period":"ytd","weight":-0.0098}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"贵州百灵企业集团制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"58484人(较上一季度减少0.72%)","perCapita":"19695股","listingDate":"2010-06-03","address":"贵州省安顺市西秀区经济技术开发区西航路212号","registeredCapital":"139759万元","survey":" 贵州百灵企业集团制药股份有限公司的主营业务是苗药研发、生产、销售。公司的主要产品是银丹心脑通软胶囊、咳速停糖浆/胶囊、复方一枝黄花喷雾剂、维C银翘片、小儿柴桂退热颗粒、强力枇杷露、双羊喉痹通颗粒。公司获得了贵州省医药产业骨干企业、全国最大的苗药研制生产企业、2025中国医药市场药企排行榜（中药）TOP100第28位、2026中药研发实力TOP50榜单、第二届“长高赛”最佳商业化潜力奖。","listedPrice":40},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ST百灵(002424)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ST百灵,002424,ST百灵股票,ST百灵股票老虎,ST百灵股票老虎国际,ST百灵行情,ST百灵股票行情,ST百灵股价,ST百灵股市,ST百灵股票价格,ST百灵股票交易,ST百灵股票购买,ST百灵股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ST百灵(002424)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}